Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested

Catharina Ihre Lundgren1, Per Hall, Paul W Dickman

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. cia.ihre-lundgren@ki.se

Cancer
|December 22, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From bench to bedside: the evolving role of iodine in thyroid cancer management.

Nature reviews. Endocrinology·2026
Same author

Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma.

Endocrine pathology·2026
Same author

ASO Visual Abstract: Socioeconomic Status and Survival in Sarcomas of the Breast: Nationwide Cohort Study.

Annals of surgical oncology·2026
Same author

Socioeconomic Status and Survival in Sarcomas of the Breast: Nationwide Cohort Study.

Annals of surgical oncology·2026
Same author

Increasing incidence and prevalence of biochemically confirmed primary hyperparathyroidism in Stockholm, 2006-2020.

The Journal of clinical endocrinology and metabolism·2026
Same author

Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study.

European journal of haematology·2026

Prognostic factors for differentiated thyroid carcinoma (DTC) include histopathology, TNM staging (metastases), and surgical completeness. These factors help predict long-term outcomes for DTC patients.

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Differentiated thyroid carcinoma (DTC) risk stratification currently utilizes various scoring systems.
  • DTC encompasses papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC).

Purpose of the Study:

  • To identify prognostic factors for long-term unfavorable outcomes in DTC.
  • To evaluate the predictive accuracy of the TNM staging system for DTC prognosis.

Main Methods:

  • A nested case-control study of 5123 DTC patients diagnosed between 1958-1987 in Sweden.
  • Matched controls were selected for cases (patients who died of DTC) based on age, gender, and diagnosis period.
  • Conditional logistic regression analyzed the effect of prognostic factors on DTC mortality.

Related Experiment Videos

Main Results:

  • Widely invasive follicular thyroid carcinoma (FTC) showed significantly higher mortality than papillary thyroid carcinoma (PTC).
  • TNM Stage IV disease, lymph node metastases, and distant metastases at diagnosis were associated with increased mortality.
  • Incomplete surgical excision correlated with higher mortality, especially in Stage I disease.

Conclusions:

  • Histopathologic subgroup, TNM staging (including lymph node and distant metastases), and completeness of surgical excision are significant prognostic factors for DTC.
  • These factors are crucial for predicting long-term outcomes in differentiated thyroid carcinoma patients.